During their lifetime, all carriers of inherited heterozygous BAP1-inactivating mutations develop at least one cancer and often multiple cancers, mostly malignant mesothelioma and uveal melanoma (called BAP1 cancer syndrome). Here, BAP1 is linked to uveal melanoma.